788 drugs of 5 therapeutic groups to review

Published: 2006-01-18 06:59:00

Updated: 2006-01-18 06:59:00

The KFDA announced on Jan. 11 that 788 drugs of 5 therapeutic groups supplied by 161 companies including anthelmintics, hemostatics and biological preparations were finally designated to review its efficacy and safety in 2006 according to "Regulation for the Drug Review Implementation".

The KF...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK